title: Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver.
authors.affiliation: Transplantation Biology Research Laboratory, St Vincent Medical Center, Los Angeles, California, USA.
authors.forename: A
authors.initials: A
authors.lastname: Baquerizo
authors.forename: A
authors.initials: A
authors.lastname: Mhoyan
authors.forename: H
authors.initials: H
authors.lastname: Shirwan
authors.forename: J
authors.initials: J
authors.lastname: Swensson
authors.forename: R W
authors.initials: RW
authors.lastname: Busuttil
authors.forename: A A
authors.initials: AA
authors.lastname: Demetriou
authors.forename: D V
authors.initials: DV
authors.lastname: Cramer
mesh_terms: D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis* / Q000097:blood; D000917:Antibody Formation; D015478:Antigens, Heterophile / Q000276:immunology*; D001011:Aorta; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D017114:Liver Failure, Acute / Q000276:immunology / Q000628:therapy*; D019164:Liver, Artificial; D013552:Swine
chemical_list: D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile